For decades, the caffeine debate has circled the wrong question — asking whether the molecule itself is friend or foe, when the deeper truth lies in what surrounds it. A sweeping review of population studies, genetic research, and clinical trials published in Circulation finds that coffee, consumed in moderation, is associated with lower risks of heart disease, stroke, and diabetes — not because of caffeine, but because of the hundreds of biologically active compounds that accompany it. Energy drinks, carrying similar caffeine loads but very different chemical company, tell a cautionary tale i